‘New Era’ To Begin For UK’s ILAP In 2025, With Focus On ‘Transformative’ Drugs

 
• By Ian Schofield
  
Transformation origami figures
The UK wants to encourage the development of "transformative" medicines (Shutterstock)

More from Agency Leadership

More from Pathways & Standards